Tag Archives: limited distribution network

Biologics by McKesson Expands Oncology Practices Offerings

Biologics has contracted with more than 500 payers and offers more than 150 therapies

AVEO Oncology’s Limited Specialty Pharmacy Distribution Network for Fotivda Selected

Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs

Soleo Health Strengthens Limited Distribution Drug Capabilities

Soleo Health has developed limited distribution networks by leveraging SoleMetrics ability to collect and deliver real-world, insightful data regarding a drug’s clinical capabilities, derived from its patients

Limited Distribution Network for DOPTELET® Includes Biologics by McKesson

Dova recently entered into a merger agreement with Swedish Orphan Biovitrum AB (Sobi)

Contracting With Specialty Pharmacies (SPs) At Your Own Peril

How a company works with and contracts with SPs will have to be rethought as a result of the initial Department of Justice (DoJ) settlement with BioScrip and ongoing investigation of Novartis in their marketing practices. When Novartis launched Exjade, it created a limited distribution network, including BioScrip and two other specialty pharmacies selected by […]

Onco360 to distribute Gilead Sciences’ Zydelig

Onco360 recently announced that it has been selected to be part of the limited network to distribute Gilead Sciences’ Zydelig (idelalisib) tablets. Onco360 is one of the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services companies. It will now be part of the highly limited Specialty Pharmacy network of Zydelig tablets, which has just […]